Acute bronchiolitis due to other specified organisms
ICD-10 J21.8 is a billable code used to indicate a diagnosis of acute bronchiolitis due to other specified organisms.
Acute bronchiolitis due to other specified organisms is a respiratory condition primarily affecting infants and young children, characterized by inflammation of the bronchioles, the small air passages in the lungs. Clinically, it presents with symptoms such as wheezing, coughing, shortness of breath, and respiratory distress. The condition is often triggered by viral infections, but in cases coded as J21.8, the causative organisms may include atypical pathogens such as Mycoplasma pneumoniae or Chlamydia pneumoniae. The anatomy involved includes the bronchioles, which are crucial for air passage and gas exchange. Disease progression can lead to significant respiratory compromise, particularly in vulnerable populations. Diagnosis typically involves a clinical evaluation supported by history, physical examination, and may include imaging or laboratory tests to identify the specific organism responsible. Differential diagnoses include other causes of wheezing and respiratory distress, such as asthma or pneumonia, which must be ruled out to ensure accurate coding and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J21.8 covers acute bronchiolitis caused by specified organisms other than the common respiratory syncytial virus (RSV), including atypical bacteria such as Mycoplasma pneumoniae and Chlamydia pneumoniae. It is essential to document the specific organism to justify the use of this code.
J21.8 should be used when the acute bronchiolitis is confirmed to be due to specified organisms other than RSV. If the causative agent is RSV, J21.0 should be used. Accurate differentiation is crucial for appropriate treatment and billing.
Documentation should include a clear clinical assessment, identification of the specific organism causing the bronchiolitis, and any relevant laboratory or imaging results. Detailed notes on the patient's symptoms and treatment response are also necessary.
